Welcome to Shanghai KASONS Technology Co., Ltd.
Back to resources
Product Updates

UDP-2-amino-2-deoxy-D-glucose disodium salt—the core nucleotide in glycosylation research

In the field of glycobiology, sugar nucleotides, as activated glycosyl donors, are the molecular cornerstones of sugar chain synthesis, protein modification and intercellular communication in living organisms. UDP-2-amino-2-deoxy-D-glucosamine disodium salt (UDP-D-glucosamine disodium salt), as an important member of the sugar nucleotide family, provides a key tool for basic scientific exploration and biomedical innovation with its unique chemical structure and biological functions. From analyzing the glycosylation mechanism to developing new glycotherapy, this compound is gradually becoming an important bridge connecting basic research and clinical application.

In the field of glycobiology, sugar nucleotides, as activated glycosyl donors, are the molecular cornerstones of sugar chain synthesis, protein modification and intercellular communication in living organisms. UDP-2-amino-2-deoxy-D-glucosamine disodium salt (UDP-D-glucosamine disodium salt), as an important member of the sugar nucleotide family, provides a key tool for basic scientific exploration and biomedical innovation with its unique chemical structure and biological functions. From analyzing the glycosylation mechanism to developing new glycotherapy, this compound is gradually becoming an important bridge connecting basic research and clinical application.

Chemical Information

Chemical name: Uridine diphosphate-2-amino-2-deoxy-D-glucose disodium salt

Common name: UDP-D-glucosamine disodium salt

Chemical formula: C15H23N3O16P2Na2

Molecular weight: 609.28 g/mol

Category: Sugar Nucleotides

Structural features

UDP-2-amino-2-deoxy-D-glucose disodium salt is composed of uridine diphosphate (UDP) and 2-amino-2-deoxy-D-glucose (glucosamine) covalently connected through a pyrophosphate bond, and exists as a disodium salt. Its structure contains multiple unique properties:

High-energy glycosyl donor design: As a classic nucleotide carrier, the UDP part can release a large amount of free energy during hydrolysis of its terminal pyrophosphate bond, driving the efficient transfer of glucosamine units to acceptor molecules such as proteins, lipids or polysaccharides to achieve glycosylation modification. This energy coupling mechanism makes it an ideal substrate in enzymatic reactions, mimicking the natural intracellular glycosylation process.

The chemical uniqueness of modified sugar groups: Compared with common glucose, glucosamine replaces the hydroxyl group with an amino group at the 2-position, forming a 2-amino-2-deoxy structure. This amino functional group not only enhances the polarity of the molecule, but also provides a reaction site for further acetylation or other derivatization, making it a direct precursor for bioactive molecules such as N-acetylglucosamine (GlcNAc). In biological systems, this structure is widely involved in post-transcriptional modifications such as O-GlcNAc glycosylation, regulating protein functions and signaling pathways.

Optimized physical and chemical properties: The disodium salt form significantly improves water solubility and stability in physiological buffers by neutralizing the charge of the phosphate group. This feature facilitates storage and operation, ensures high reaction efficiency and reduces the formation of by-products in in vitro enzymatic experiments or synthetic systems. In addition, the synergistic effect of C-C and C-N bonds makes the overall molecular conformation flexible and easy to be recognized and catalyzed by glycosyltransferases.

Main applications and advantages

Core biochemical tools for analyzing glycosylation mechanisms

Glycosylation is one of the most complex post-translational modifications in life, involved in development, immunity and disease processes. As a specific substrate, UDP-glucosamine disodium salt can be used for kinetic studies of glycosyltransferases, inhibitor screening and structure-function relationship analysis. For example, in cancer research, abnormal O-GlcNAc glycosylation is associated with tumor metabolic reprogramming. This compound can be used to reconstruct the extracellular enzyme reaction system and explore the role of glycosylation in the regulation of gene expression. At the same time, it is also a key raw material for the preparation of sugar chips, which is used for high-throughput screening of sugar-protein interactions to reveal the molecular basis of pathogen infection or cell adhesion.

Key raw materials for biopharmaceuticals and glycoengineering

With the development of biological drugs such as monoclonal antibodies and glycoprotein hormones, glycosylation uniformity directly affects drug efficacy and safety. The compound provides a standardized substrate for enzymatic glycosylation or cell-free synthesis systems for the preparation of glycoform-specific therapeutic proteins, thereby optimizing pharmacokinetic properties (such as half-life extension) and reducing immunogenicity. In the field of vaccines, it can be used as a precursor for the synthesis of bacterial capsular polysaccharide analogs to facilitate the development of polysaccharide conjugate vaccines. In addition, in synthetic biology, UDP-glucosamine can be integrated into artificial metabolic pathways to achieve large-scale production of rare sugar derivatives.

Elements of metabolic research and disease model construction

Glucosamine metabolism is closely related to insulin resistance, neurodegenerative diseases, and inflammation. As an intermediate in the intracellular amino sugar synthesis pathway, this compound can be used in isotope labeling experiments (such as ¹³C-glucosamine tracking) to dynamically analyze the flow direction and flux of sugar amines and reveal the mechanism of metabolic disorders. In disease models, exogenous addition of UDP-glucosamine can simulate glycosylation imbalance under pathological conditions, help evaluate the impact of related enzyme mutations, and provide a platform for identification of drug targets for metabolic diseases.

The cornerstone of enzymatic diagnosis and biomarker development

Glycosyltransferase activity testing has potential in the diagnosis of genetic diseases (such as congenital disorders of glycosylation) and cancer monitoring. Using UDP-glucosamine disodium salt as a substrate, fluorescence, colorimetric or mass spectrometry detection methods can be constructed to quantify specific enzyme activities in serum or tissue samples to assist early screening and efficacy evaluation. In addition, certain diseases (such as rheumatoid arthritis) are accompanied by changes in glycosylation patterns. This compound can be used as a tool to develop diagnostic reagents based on sugar chain analysis to promote the development of precision medicine.

Conclusion

Although UDP-2-amino-2-deoxy-D-glucose disodium salt does not appear in macroscopic life phenomena, it is an indispensable energy carrier and building block in the microscopic sugar world. From decoding glycosylation codes to empowering the next generation of carbohydrate drugs, it silently supports the cutting-edge exploration of glycoscience. With the intersection of glycobiology and synthetic chemistry, this molecule will continue to play a cornerstone role in basic research, drug development and diagnostic innovation, contributing unique value to human health.

The above information is provided by the editor of KASONS and is for scientific research only.